IRVINE, Calif., Aug. 8 -- Graseby Medical Limited (United
Kingdom) and Masimo Corporation (Irvine, Calif.) today announced a purchasing
and licensing agreement under which Graseby will integrate Masimo Signal
Extraction pulse oximetry technology into its future patient monitors. Graseby
is a leading manufacturer of medical equipment, including Infusion Pumps, Apnoea
Monitors and Masimo is a recognised leader in pulse oximetry
technology.
Graseby today announced its plans to first include Masimo
SET® technology in their new infant monitor, labelled the MR30. The MR30
combines ECG, Respiration and Masimo SET pulse oximetry vital signs monitoring
in a compact, portable, cost-effective package that is ideal for monitoring
patients in hospital and non-hospital settings. The MR30 is designed to monitor
infants at risk of Alternative Life Threatening Events (ALTE's) and Sudden
Infant Death Syndrome (SIDS), one of the leading causes of death in
infants.
"The measurement of blood oxygenation via pulse oximetry is now
thought to be a promising method of detecting apnoea episodes. Even considering
how babies tend to move during sleep, we believe that Masimo SET pulse oximetry
technology is sensitive and reliable enough to monitor babies at risk of SIDS,''
stated Chris Hutchison, Managing Director of Graseby. "Masimo SET has been
proven to work well during motion and low perfusion. In the home setting parents
have to rely on the accuracy of the monitor because immediate action is
essential in the event of an apnoea episode. Masimo SET ensures accurate
detection of true events while minimising false alarms, which are not only an
annoyance for the family, but also could desensitise parents to true
alarms.''
Joe E. Kiani, President and CEO of Masimo Corporation, stated,
"Graseby has chosen Masimo SET as their pulse oximetry platform because of the
technology's unprecedented fidelity, sensitivity and specificity. We are happy
to be in partnership with Graseby, because they share our commitment to putting
patients and customers ahead of all other priorities.''
Graseby designs,
manufactures and markets Infusion Pumps and Apnoea Monitors. Graseby is based in
Watford, UK and its products are available worldwide.
Masimo
Corporation, founded in 1989, is a privately held medical technology company
that develops, licenses and markets advanced medical signal processing
technologies and products for the non-invasive monitoring of vital signs. Masimo
Signal Extraction Technology represents a fundamental departure from
conventional pulse oximetry technologies. Over 40 independent, published studies
have demonstrated that Masimo Signal Extraction Technology substantially
overcomes the limitations of conventional pulse oximeters in accurately
measuring arterial blood oxygen saturation levels and pulse rates in the
presence of patient movement and low perfusion. To date, Masimo has licensed its
Signal Extraction pulse oximetry technology to over 35 international patient
monitoring system providers, which make up over 60% of the world's pulse
oximeter shipments. AmeriNet, a leading group purchasing organisation and
HealthTrust Columbia, the largest hospital system in America are offering their
member hospitals the ability to gain access to Masimo SET technology at group
purchasing discounted prices. Masimo is headquartered in Irvine, California.
Additional information about Masimo and its products can be found on the
company's web site www.masimo.com. |
